{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:45:02Z","timestamp":1791755102378,"version":"4.3.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Thiamine metabolism dysfunction syndrome 5 (TMDS5) is a rare inborn error of metabolism caused by variants in <jats:italic>TPK1<\/jats:italic>, leading to reduced TPK levels. This enzyme is crucial for the production of thiamine pyrophosphate, the active form of thiamine, a vital coenzyme in numerous metabolic pathways. The clinical presentation exhibits a diverse range of manifestations. In this review, we explore reported cases in the literature and present two cases representing the extremes of the clinical spectrum: recurrent ataxia and Leigh syndrome. The former phenotype follows a milder course. The second one is characterized by early onset and severe symptoms, including dystonia, epilepsy, and developmental regression, progressing rapidly to severe disability with high mortality. Typically, children exposed to infectious or traumatic triggers display episodes marked by ataxia and dystonia, with periods of good health or only mild disabilities in between. Treatment with the phosphorylated thiamine active bioform, TPP, is more effective in the recurrent ataxia form, especially when initiated promptly at symptom onset. Further studies are needed to identify available biomarkers and establish correlations between different variants, severity, and treatment response.<\/jats:p>","DOI":"10.1186\/s13023-025-03665-9","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T05:35:57Z","timestamp":1743831357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The wide phenotypic spectrum of thiamine metabolism dysfunction syndrome 5 and its treatment"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1057-0995","authenticated-orcid":false,"given":"Alice","family":"Dallan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0447-2112","authenticated-orcid":false,"given":"Giuseppe","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Canavese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5690-6504","authenticated-orcid":false,"given":"Diana","family":"Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1239-0829","authenticated-orcid":false,"given":"Maria","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5230-2831","authenticated-orcid":false,"given":"Andrea","family":"Gazzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3899-4867","authenticated-orcid":false,"given":"Francesco","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2795-6013","authenticated-orcid":false,"given":"Alessandro","family":"Mussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"issue":"4","key":"3665_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jimd.12125","volume":"42","author":"A Marc\u00e9-Grau","year":"2019","unstructured":"Marc\u00e9-Grau A, Mart\u00ed-S\u00e1nchez L, Baide-Mairena H, Ortigoza-Escobar JD, P\u00e9rez-Due\u00f1as B. Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies. J Inherit Metab Dis. 2019;42(4):581\u201397. https:\/\/doi.org\/10.1002\/jimd.12125.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"3665_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1055\/s-0040-1715628","volume":"52","author":"CT R\u00fcsch","year":"2021","unstructured":"R\u00fcsch CT, et al. Thiamine pyrophosphokinase deficiency due to mutations in the TPK1 gene: A rare, treatable neurodegenerative disorder. Neuropediatrics. 2021;52(2):126\u201332. https:\/\/doi.org\/10.1055\/s-0040-1715628.","journal-title":"Neuropediatrics"},{"issue":"2","key":"3665_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1515\/jpem-2020-0139","volume":"34","author":"F Porta","year":"2021","unstructured":"Porta F, et al. SLC25A19 deficiency and bilateral striatal necrosis with polyneuropathy: A new case and review of the literature. J Pediatr Endocrinol Metab. 2021;34(2):261\u20136. https:\/\/doi.org\/10.1515\/jpem-2020-0139.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3665_CR4","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.ajhg.2011.11.007","volume":"89","author":"JA Mayr","year":"2011","unstructured":"Mayr JA, et al. Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway. Am J Hum Genet. 2011;89:806\u201312. https:\/\/doi.org\/10.1016\/j.ajhg.2011.11.007.","journal-title":"Am J Hum Genet"},{"key":"3665_CR5","doi-asserted-by":"publisher","unstructured":"Thompson ZE, Boyd NK, Khoshnood MM, Santoro JD. Thiamine metabolism dysfunction syndrome 5 (THMD5) mimicking acute disseminated encephalomyelitis. Am. J. Med. Genet. Part A. no. July, 2023:1\u20135 https:\/\/doi.org\/10.1002\/ajmg.a.63376","DOI":"10.1002\/ajmg.a.63376"},{"key":"3665_CR6","doi-asserted-by":"publisher","unstructured":"Zhao D et al. Thiamine pyrophosphokinase deficiency: report of two Chinese cases and a literature review. Front. Pediatr. 2023;11, no. August:1\u201311 https:\/\/doi.org\/10.3389\/fped.2023.1173787","DOI":"10.3389\/fped.2023.1173787"},{"key":"3665_CR7","doi-asserted-by":"publisher","unstructured":"Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med Off J Am Coll Med Genet. May 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","DOI":"10.1038\/gim.2015.30"},{"issue":"2","key":"3665_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-0040-1715631","volume":"52","author":"M Eckenweiler","year":"2021","unstructured":"Eckenweiler M, Mayr JA, Gr\u00fcnert S, Abicht A, Korinthenberg R. Thiamine treatment and favorable outcome in an infant with biallelic TPK1 variants. Neuropediatrics. 2021;52(2):123\u20135. https:\/\/doi.org\/10.1055\/s-0040-1715631.","journal-title":"Neuropediatrics"},{"issue":"4","key":"3665_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ymgme.2014.09.010","volume":"113","author":"S Banka","year":"2014","unstructured":"Banka S, et al. Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: A treatable neurological disorder caused by TPK1 mutations. Mol Genet Metab. 2014;113(4):301\u20136. https:\/\/doi.org\/10.1016\/j.ymgme.2014.09.010.","journal-title":"Mol Genet Metab"},{"issue":"7","key":"3665_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1542\/pir.2017-0223","volume":"40","author":"P Overby","year":"2019","unstructured":"Overby P, Kapklein M, Jacobson RI. Acute ataxia in children. Pediatr Rev. 2019;40(7):332\u201343. https:\/\/doi.org\/10.1542\/pir.2017-0223.","journal-title":"Pediatr Rev"},{"key":"3665_CR11","doi-asserted-by":"publisher","unstructured":"Plecko B. TPK1 Deficiency-A Vitamin-Responsive Encephalopathy with a Suggestive MRI Pattern. Neuropediatrics, Germany. Apr. 2021;52(2):69\u201370,, https:\/\/doi.org\/10.1055\/s-0041-1725949","DOI":"10.1055\/s-0041-1725949"},{"key":"3665_CR12","doi-asserted-by":"publisher","unstructured":"Mahajan A, Sidiropoulos C. TPK1 mutation induced childhood onset idiopathic generalized dystonia: report of a rare mutation and effect of deep brain stimulation. J Neurol Sci. May 2017;376:42\u20133. https:\/\/doi.org\/10.1016\/j.jns.2017.02.063.","DOI":"10.1016\/j.jns.2017.02.063"},{"issue":"3","key":"3665_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1515\/jpem-2018-0363","volume":"32","author":"L Zhu","year":"2019","unstructured":"Zhu L, et al. Identification of two novel TPK1 gene mutations in a Chinese patient with thiamine pyrophosphokinase deficiency undergoing whole exome sequencing. J Pediatr Endocrinol Metab. 2019;32(3):295\u2013300. https:\/\/doi.org\/10.1515\/jpem-2018-0363.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3665_CR14","doi-asserted-by":"publisher","unstructured":"Nyhan WL, McGowan K, Barshop BA. Thiamine phosphokinase deficiency and mutation in TPK1 presenting as biotin responsive basal ganglia disease. Clin. Chim. Acta. November 2017;499:13\u201315, 2019. https:\/\/doi.org\/10.1016\/j.cca.2019.07.034","DOI":"10.1016\/j.cca.2019.07.034"},{"key":"3665_CR15","doi-asserted-by":"publisher","unstructured":"Au LWC, et al. Movement disorders associated with thiamine pyrophosphokinase deficiency: intrafamilial variability in the phenotype. Clin Neurol Neurosurg. Dec. 2020;199:106258. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106258.","DOI":"10.1016\/j.clineuro.2020.106258"},{"key":"3665_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ymgmr.2013.12.007","volume":"1","author":"JL Fraser","year":"2014","unstructured":"Fraser JL, et al. Thiamine pyrophosphokinase deficiency causes a Leigh disease like phenotype in a sibling pair: identification through whole exome sequencing and management strategies. Mol Genet Metabolism Rep. 2014;1:66\u201370. https:\/\/doi.org\/10.1016\/j.ymgmr.2013.12.007. United States.","journal-title":"Mol Genet Metabolism Rep"},{"issue":"7","key":"3665_CR17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/14737175.2016.1187562","volume":"16","author":"JD Ortigoza-Escobar","year":"2016","unstructured":"Ortigoza-Escobar JD, et al. Treatment of genetic defects of thiamine transport and metabolism. Expert Rev Neurother. 2016;16(7):755\u201363. https:\/\/doi.org\/10.1080\/14737175.2016.1187562.","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"3665_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00438-018-1517-3","volume":"294","author":"W Huang","year":"2019","unstructured":"Huang W, et al. Reduced thiamine binding is a novel mechanism for TPK deficiency disorder. Mol Genet Genomics. 2019;294(2):409\u201316. https:\/\/doi.org\/10.1007\/s00438-018-1517-3.","journal-title":"Mol Genet Genomics"},{"key":"3665_CR19","doi-asserted-by":"publisher","unstructured":"Wang J, Chen X, Mei A. [Clinical characteristics and genetic analysis of a Chinese pedigree affected with thiamine pyrophosphokinase deficiency]. Zhonghua yi xue yi chuan xue za zhi\u2009=\u2009Zhonghua yixue yichuanxue zazhi\u2009=\u2009Chinese J. Med. Genet. Feb. 2021;38(2):141\u2013144 https:\/\/doi.org\/10.3760\/cma.j.cn511374-20191208-00627","DOI":"10.3760\/cma.j.cn511374-20191208-00627"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03665-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03665-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03665-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T05:35:59Z","timestamp":1743831359000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03665-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3665"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03665-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"26 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval was obtained from the Intercompany Ethics Committee of A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, A.O. Ordine Mauriziano di Torino and A.S.L. Citt\u00e0 di Torino, with application number 256\/2022, protocol number 17\/06\/2022. Informed consent was obtained from parents of participants prior to their inclusion in the study and archived by authors according to the local ethics committee\u2019s policy. The study was conducted in accordance with the ethical principles enshrined in the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication of the clinical details and any accompanying images was obtained from parents of participants and archived by authors according to the local ethics committee\u2019s policy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}